39 results
6-K
EX-99.1
MREO
Mereo Biopharma Group Plc
6 Jul 23
Ultragenyx Announces First Patients Dosed in Phase 3 Program
8:05am
approvals, the ability of the company and Mereo BioPharma to successfully develop UX143, the company’s ability to achieve its projected development goals
F-4
EX-10.6
MREO
Mereo Biopharma Group Plc
25 Jan 19
Registration of securities (foreign)
12:00am
will pay Consultant a retainer of $25,550 per month.
The Parties also agree that upon achievement of agreed upon goals, Consultant will be eligible
6-K
EX-99.1
MREO
Mereo Biopharma Group Plc
5 Jun 23
Ultragenyx and Mereo BioPharma Announce Positive Data from the Ongoing Phase 2/3 Orbit
4:37pm
development goals in its expected timeframes, risks related to adverse side effects, risks related to reliance on third party partners to conduct
6-K
EX-99.1
MREO
Mereo Biopharma Group Plc
17 Oct 23
Current report (foreign)
7:01am
projected development goals in its expected timeframes, risks related to adverse side effects, risks related to reliance on third party partners
S-8
EX-99.1
MREO
Mereo Biopharma Group Plc
15 Jan 21
Registration of securities for employees
4:21pm
, the performance goals to be achieved during any Performance Period, the length of any Performance Period, the amount of any Performance Award granted … thereafter during which any performance goals specified by the Committee with respect to such Award are measured.
(t) “Person” means a natural person
S-8
EX-99.1
jrao ymzvzlwcvuhs
18 Feb 20
Registration of securities for employees
5:17pm
20-F
EX-4.7
6dqcpa8wwtv0915r
29 Apr 19
Annual report (foreign)
4:59pm
S-8
EX-99.1
6a3dex
21 May 19
Registration of securities for employees
1:53pm
F-4
EX-10.11
oig0ivk04qcoc7 8bos6
25 Jan 19
Registration of securities (foreign)
12:00am
F-4
EX-10.13
a126twdqjg1u3 veqh1n
25 Jan 19
Registration of securities (foreign)
12:00am
F-4
EX-10.10
ju0u063k3c08k m5
25 Jan 19
Registration of securities (foreign)
12:00am
F-4
EX-10.12
f0c877jt0gjl8b 31
25 Jan 19
Registration of securities (foreign)
12:00am
F-4
EX-10.8
evsth
25 Jan 19
Registration of securities (foreign)
12:00am
F-4
EX-10.9
s3sb x9s84knuogm
25 Jan 19
Registration of securities (foreign)
12:00am
20-F
EX-4.19
a5753svi6db
29 Apr 19
Annual report (foreign)
4:59pm
DEF 14A
o4oyfx4avyxdios
24 Apr 24
Definitive proxy
7:30am
6-K
EX-99.1
9m6ex48pneqcvg2w1s
31 Aug 22
Letter Reiterates Mereo’s Updated Strategic Plan to Maximize Value for All Shareholders and Corrects Rubric’s Assumptions
7:57am